Mizuho Initiates Coverage On Medtronic with Buy Rating, Announces Price Target of $100
Mizuho analyst Anthony Petrone initiates coverage on Medtronic (NYSE:MDT) with a Buy rating and announces Price Target of $100.
Why Jim Cramer Says He Likes This Stock Over Medtronic
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Boston Scientific Corporation (NYSE: BSX) is a much better company than Medtronic plc (NYSE: MDT).
Some Medtronic’s Insulin Pumps Are Associated With Cybersecurity Risk, FDA Says
The FDA warned that certain types of Medtronic Inc’s (NYSE:MDT) MiniMed 600 Series insulin pump system were vulnerable to cyberattacks. Hackers could…
‘I Just Want Nothing To Do With It’: Cramer Calls This Is A Speculative Stock, Analysts Disagree
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Marathon Digital Holdings Inc (NASDAQ: MARA) is a speculative company.
Medtronic Announced Symplicity HTN-3 Trial Data Show Sustained Long-term Blood Pressure Reductions With Medtronic Renal Denervation Procedure
Medtronic plc (NYSE: MDT) today announced long-term results from the SYMPLICITY HTN-3 clinical trial.
What Are Whales Doing With Medtronic
A whale with a lot of money to spend has taken a noticeably bullish stance on Medtronic.
Looking at options history for Medtronic (NYSE:MDT) we detected 10 strange trades.
10 Health Care Stocks Whale Activity In Today’s Session
This whale alert can help traders discover the next big trading opportunities.
Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner.
Ra Medical Systems Announced Definitive Merger Agreement with Catheter Precision; Merger Structured as Stock for Stock Reverse Merger
Ra Medical Systems, Inc. (NYSE American: RMED) ("Ra Medical" or the "Company") announces it has entered into an Agreement and Plan of Merger (the "Definitive Merger Agreement") with privately held Catheter Precision, Inc.